Vistin Pharma ASA (OSL:VISTN)
22.00
+0.30 (1.38%)
At close: Oct 23, 2025
Vistin Pharma ASA Revenue
Vistin Pharma ASA had revenue of 117.67M NOK in the quarter ending June 30, 2025, with 10.92% growth. This brings the company's revenue in the last twelve months to 452.25M, up 2.64% year-over-year. In the year 2024, Vistin Pharma ASA had annual revenue of 429.50M, down -2.01%.
Revenue (ttm)
452.25M
Revenue Growth
+2.64%
P/S Ratio
2.16
Revenue / Employee
6.20M
Employees
75
Market Cap
975.58M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 429.50M | -8.83M | -2.01% |
| Dec 31, 2023 | 438.33M | 133.48M | 43.78% |
| Dec 31, 2022 | 304.85M | 26.23M | 9.41% |
| Dec 31, 2021 | 278.62M | 24.72M | 9.73% |
| Dec 31, 2020 | 253.91M | 25.78M | 11.30% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Medistim ASA | 628.08M |
| Nordhealth AS | 578.17M |
| Navamedic ASA | 523.56M |
| Photocure ASA | 522.86M |
| Omda AS | 458.96M |
| Gentian Diagnostics ASA | 163.38M |
| ContextVision AB | 122.97M |
| ArcticZymes Technologies ASA | 104.33M |